Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Whole Blood Mitigates the Acute Coagulopathy of Trauma and Avoids the Coagulopathy of Crystalloid Resuscitation.

Sheppard FR, Schaub LJ, Cap AP, Macko AR, Moore HB, Moore EE, Glaser JJ.

J Trauma Acute Care Surg. 2018 Aug 17. doi: 10.1097/TA.0000000000002046. [Epub ahead of print]


Whole blood and Hextend: Bookends of modern tactical combat casualty care field resuscitation and starting point for multifunctional resuscitation fluid development.

Sheppard FR, Mitchell TA, Macko AR, Fryer DM, Schaub LJ, Ozuna KM, Glaser JJ.

J Trauma Acute Care Surg. 2018 Jul;85(1S Suppl 2):S33-S38. doi: 10.1097/TA.0000000000001772.


All animals are equal but some animals are more equal than others: Plasma lactate and succinate in hemorrhagic shock-A comparison in rodents, swine, nonhuman primates, and injured patients.

Reisz JA, Wither MJ, Moore EE, Slaughter AL, Moore HB, Ghasabyan A, Chandler J, Schaub LJ, Fragoso M, Nunns G, Silliman CC, Hansen KC, Banerjee A, Sheppard FR, D'Alessandro A.

J Trauma Acute Care Surg. 2018 Mar;84(3):537-541. doi: 10.1097/TA.0000000000001721.


Nonhuman primate model of polytraumatic hemorrhagic shock recapitulates early platelet dysfunction observed following severe injury in humans.

Schaub LJ, Moore HB, Cap AP, Glaser JJ, Moore EE, Sheppard FR.

J Trauma Acute Care Surg. 2017 Mar;82(3):461-469. doi: 10.1097/TA.0000000000001343.


Severe Hemorrhagic Shock Induces Acute Activation and Expansion of IL-8+/IL-10+ Neutrophils with Enhanced Oxidative Reactivity in Non-Human Primates.

Vernon PJ, Paredes RM, Sooter AJ, Schaub LJ, Grossman HM, Pusateri AE, Glaser JJ, Sheppard FR.

Shock. 2016 Sep;46(3 Suppl 1):129-36. doi: 10.1097/SHK.0000000000000643.


Rapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine Responses.

Vernon PJ, Schaub LJ, Dallelucca JJ, Pusateri AE, Sheppard FR.

PLoS One. 2015 Dec 30;10(12):e0146105. doi: 10.1371/journal.pone.0146105. eCollection 2015.


Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.

Fiskus W, Sharma S, Qi J, Valenta JA, Schaub LJ, Shah B, Peth K, Portier BP, Rodriguez M, Devaraj SG, Zhan M, Sheng J, Iyer SP, Bradner JE, Bhalla KN.

Mol Cancer Ther. 2014 May;13(5):1142-54. doi: 10.1158/1535-7163.MCT-13-0770. Epub 2014 Jan 16.


Thermal unfolding of the N-terminal region of p53 monitored by circular dichroism spectroscopy.

Schaub LJ, Campbell JC, Whitten ST.

Protein Sci. 2012 Nov;21(11):1682-8. doi: 10.1002/pro.2146. Epub 2012 Sep 25.

Supplemental Content

Loading ...
Support Center